HedgePath Pharmaceuticals (HPPI) signed an exclusive supply and license agreement with Australia-based firm Mayne Pharma International, whereby HPPI will pursue clinical development of Mayne Pharma’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results